Inhibition of ERK1/2 Restores GSK3β Activity and Protein Synthesis Levels in a Model of Tuberous Sclerosis
Abstract Tuberous sclerosis (TS) is a multi-organ autosomal dominant disorder that is best characterized by neurodevelopmental deficits and the presence of benign tumors. TS pathology is caused by mutations in tuberous sclerosis complex (TSC) genes and is associated with insulin resistance, decrease...
Enregistré dans:
Auteurs principaux: | Rituraj Pal, Vitaliy V. Bondar, Carolyn J. Adamski, George G. Rodney, Marco Sardiello |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a4d9a93f97c34c3c8f582aba8a8ebcdd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
par: Xiaolong Tang, et autres
Publié: (2021) -
Case report on tuberous sclerosis
par: Nadezhda V. Krasnova, et autres
Publié: (2021) -
The genomic landscape of tuberous sclerosis complex
par: Katie R. Martin, et autres
Publié: (2017) -
Long-term undiagnosed tuberous sclerosis
par: Tatyana N. Varenova, et autres
Publié: (2021) -
FSC231 alleviates paclitaxel‐induced neuralgia by inhibiting the interactions between PICK1 and GluA2 and activates GSK‐3β and ERK1/2
par: Xi Zhang, et autres
Publié: (2021)